The U.S. Food and Drug Administration has granted Breakthrough Device designation to MeMed BV Flex, a blood test that differentiates between bacterial and viral infections.
This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results